CreditReports.dk
HomeScreen companies

BIOPHARMA HOLDING ApS Financials, key figures and credit report

CVR number: 35206086 Established 2013 Industry: 64 Financial service activities, except insurance and pension funding
Company contact details
Slotsmarken 12, 2970 Hørsholm
Gross profit 921.4 kDKK FY 2024 -2.9% vs 2023
EBIT -16.0 kDKK FY 2024 -142% vs 2023
Net debt -90.5 kDKK FY 2024 +99.9% vs 2023
Quick ratio 13.4 FY 2024 -1.1 vs 2023

Company information

Official name
BIOPHARMA HOLDING ApS
Established
2013
Company form
Private limited company
Industry

Data sources and methodology

The information about BIOPHARMA HOLDING ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2024.

Open the 2024 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About BIOPHARMA HOLDING ApS

BIOPHARMA HOLDING ApS (CVR number: 3520608-6) is a company from HØRSHOLM. The company recorded a gross profit of 921.4 kDKK in 2024. The operating profit was -16 kDKK, while net earnings were -3732.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 2.3 %, which can be considered weak but Return on Equity (ROE) was -6.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 93 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. BIOPHARMA HOLDING ApS's liquidity measured by quick ratio was 13.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2020
2021
2022
2023
2024
Volume
Net sales
Gross profit592.00706.001 194.00949.00921.36
EBIT-72.0083.00379.0038.00-15.96
Net earnings1 495.0012 016.00-29 722.00-20 576.00-3 732.68
Shareholders equity total146 262.00158 277.00128 557.00107 979.002 921.10
Balance sheet total (assets)151 158.00167 311.00137 802.00115 941.003 139.74
Net debt4 698.008 812.008 931.00-80 523.00-90.52
Profitability
EBIT-%
ROA1.1 %10.4 %-19.4 %1.7 %2.3 %
ROE1.0 %7.9 %-20.7 %-17.4 %-6.7 %
ROI1.1 %10.4 %-19.4 %1.7 %2.3 %
Economic value added (EVA)-7 567.59-7 504.45-8 023.70-6 880.32-5 838.04
Solvency
Equity ratio96.8 %94.6 %93.3 %93.1 %93.0 %
Gearing3.2 %5.6 %7.1 %7.3 %
Relative net indebtedness %
Liquidity
Quick ratio0.10.12.914.513.4
Current ratio0.10.12.914.513.4
Cash and cash equivalents34.00129.00190.0088 404.0090.52
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2024
2.31%
Rating 32/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2024
93.0%
Rating 74/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of BIOPHARMA HOLDING ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated